Michael Emami

Research Project:

Michael is interested in developing genetic therapeutic strategies for Duchenne muscular dystrophy (DMD).

Publications:

Polyrotaxane Nanocarriers Can Deliver CRISPR/Cas9 Plasmid to Dystrophic Muscle Cells to Successfully Edit the DMD GeneEmami MR, Young CS, Ji Y, Liu X, Mokhonova, E., Pyle, A. D., Meng, H. and Spencer, M. J. (2019), Polyrotaxane Nanocarriers Can Deliver CRISPR/Cas9 Plasmid to Dystrophic Muscle Cells to Successfully Edit the DMD Gene. Adv. Therap. 2019. doi: 1002/adtp.201900061